Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
YVOIRE Y-Solution is a premium line of hyaluronic acid (HA) dermal fillers developed by LG Chem, utilizing their proprietary HICE (High Concentration Equalized) cross-linking technology. This technology enables a high concentration of HA with minimal cross-linking agents, resulting in a product with high elasticity and viscosity suitable for deep volumizing and contouring. The Y-Solution range includes specific formulations such as Y-Solution 360, 540, and 720, which are optimized for different anatomical areas and injection depths, including the lips, nasolabial folds, mid-face, and jawline. The products are designed to provide natural-looking aesthetic improvements by restoring lost volume and smoothing deep wrinkles through physical tissue support and hydration.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on YVOIRE Y-Solution.